GCM
RTO icon

Glenview Capital Management’s Rentokil RTO Stock Holding History

Glenview Capital Management’s Portfolio RTO Stock Details RTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-205,175
Closed -$6.04M – 59
2025
Q4 		$6.04M Hold
205,175
– – 0.12% 53
2025
Q3 		$5.18M Buy
+205,175
New +$5M 0.12% 52

Other funds holding RTO

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GCM
Gates Capital Management New York $4.16B AUM 21% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
SL
Summitry LLC Foster City, California $3.04B AUM 17.05% 1-Year Est. Return

Glenview Capital Management's RTO Position: Q1 2026 in Review

Glenview Capital Management sold out of Rentokil (RTO) in Q1 2026, closing a stake of 205,175 shares — an estimated $6.04M sold.

Glenview Capital Management first reported a position in RTO in Q3 2025 and held it in 2 quarters. The position peaked at $6.04M in Q4 2025. 284 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Glenview Capital Management reported no remaining Rentokil position as of Q1 2026 after selling out during the quarter.
  • Glenview Capital Management sold 205,175 Rentokil shares in Q1 2026, an estimated $6.04M.
  • Glenview Capital Management first reported a position in Rentokil in Q3 2025 and held it in 2 quarters.
  • Glenview Capital Management's Rentokil position peaked at $6.04M in Q4 2025.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Glenview Capital Management's 13F filing for Q1 2026, filed 15 May 2026.